Clinical trials recruiting for Pancreatic Carcinoma
16
Recruiting trials
38
US states with sites
16
Countries
12%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CEB-01 | 1 |
| Cancer Therapeutic Procedure | 1 |
| HER3-DXd | 1 |
| Lanreotide | 1 |
| MGC028 | 1 |
| Mesothelin and Claudin 18.2 CAR-T cells | 1 |
| XNW28012 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 6 |
| Illinois | 4 |
| Maryland | 4 |
| Minnesota | 4 |
| Arizona | 3 |
| Florida | 3 |
| Michigan | 3 |
| Missouri | 3 |
| New York | 3 |
| Ohio | 3 |
| Washington | 3 |
| Wisconsin | 3 |
Top cities
St Louis, Missouri 3Atlanta, Georgia 2Baltimore, Maryland 2Boston, Massachusetts 2Chicago, Illinois 2Columbus, Ohio 2Duarte, California 2Grand Rapids, Michigan 2Milwaukee, Wisconsin 2New York, New York 2
Self-screener
Recruiting trials
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- A Study of MGC028 in Participants With Advanced Solid Tumors
- CEB-01 in Locally Resectable Pancreatic Cancer
- Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma
- Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
- Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
- Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
- Pancreatic Cancer Detection Consortium
- Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
- Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
- Use Of Indocyanine Green In Pancreas Surgery
Related conditions
Trials recruiting for Pancreatic Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Lung cancer 2180Prostate cancer 1234Ovarian Carcinoma 10Colorectal Carcinoma 42Cholangiocarcinoma 32Breast cancer 2239Prostate Carcinoma 35Pancreatic Cancer Non-resectable 10Melanoma 487
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pancreatic Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.